驱动基因-话题@MedSci

#驱动基因#

29篇内容 | 2202人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2179819, encodeId=56e121e981971, content=<a href='/topic/show?id=77e66814e1f' target=_blank style='color:#2F92EE;'>#狼疮性肾炎#</a> <a href='/topic/show?id=a7fe6919e29' target=_blank style='color:#2F92EE;'>#生物信息学#</a> <a href='/topic/show?id=34a110150800' target=_blank style='color:#2F92EE;'>#驱动基因#</a>, objectTitle=Front Immunol:基于综合生物信息学和机器学习的狼疮性肾炎驱动基因鉴定, objectType=article, longId=808577, objectId=e48a8085e7a7, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20230321/1679467481359_4754896.jpeg, objectUrl=/article/show_article.do?id=e48a8085e7a7, replyNumber=0, likeNumber=151, createdTime=2024-01-07, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=e48a8085e7a7, moduleTitle=Front Immunol:基于综合生物信息学和机器学习的狼疮性肾炎驱动基因鉴定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e48a8085e7a7)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1661498, encodeId=9495166149885, content=<a href='/topic/show?id=34a110150800' target=_blank style='color:#2F92EE;'>#驱动基因#</a>, objectTitle=肺癌丨真实世界数据，哪些驱动基因突变可获益于免疫治疗, objectType=article, longId=731977, objectId=f58ee319779e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f58ee319779e, replyNumber=0, likeNumber=0, createdTime=2023-06-04, rootId=0, userName=751943081_32627957, userId=b94625296381, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f58ee319779e, moduleTitle=肺癌丨真实世界数据，哪些驱动基因突变可获益于免疫治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f58ee319779e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1661497, encodeId=8dd8166149e5c, content=<a href='/topic/show?id=34a110150800' target=_blank style='color:#2F92EE;'>#驱动基因#</a>, objectTitle=Transl Lung Cancer Res: 无驱动基因突变的转移性NSCLC患者二线多西他赛+ramucirumab（雷莫芦单抗）治疗的疗效, objectType=article, longId=295315, objectId=4e7b295315f7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4e7b295315f7, replyNumber=0, likeNumber=122, createdTime=2022-08-29, rootId=0, userName=751943081_32627957, userId=b94625296381, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4e7b295315f7, moduleTitle=Transl Lung Cancer Res: 无驱动基因突变的转移性NSCLC患者二线多西他赛+ramucirumab（雷莫芦单抗）治疗的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4e7b295315f7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1661496, encodeId=5b99166149609, content=<a href='/topic/show?id=34a110150800' target=_blank style='color:#2F92EE;'>#驱动基因#</a>, objectTitle=J Thorac Oncol：Durvalumab +tremelimumab联合或不联合化疗一线治疗驱动基因阴性的转移性NSCLC患者的疗效和安全性, objectType=article, longId=220795, objectId=abf7220e9596, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=abf7220e9596, replyNumber=0, likeNumber=93, createdTime=2022-09-29, rootId=0, userName=751943081_32627957, userId=b94625296381, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=abf7220e9596, moduleTitle=J Thorac Oncol：Durvalumab +tremelimumab联合或不联合化疗一线治疗驱动基因阴性的转移性NSCLC患者的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=abf7220e9596)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1661495, encodeId=c2351661495dc, content=<a href='/topic/show?id=34a110150800' target=_blank style='color:#2F92EE;'>#驱动基因#</a>, objectTitle=贝伐珠单抗在肺癌驱动基因阴性的治疗, objectType=article, longId=220747, objectId=11d1220e47cc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=11d1220e47cc, replyNumber=0, likeNumber=84, createdTime=2022-01-11, rootId=0, userName=751943081_32627957, userId=b94625296381, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=11d1220e47cc, moduleTitle=贝伐珠单抗在肺癌驱动基因阴性的治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=11d1220e47cc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1661493, encodeId=d7051661493dd, content=<a href='/topic/show?id=34a110150800' target=_blank style='color:#2F92EE;'>#驱动基因#</a>, objectTitle=Clin Lung Cancer: Atezolizumab联合ipilimumab治疗经治的驱动基因阴性的晚期非小细胞肺癌（NSCLC）的安全性和疗效, objectType=article, longId=217906, objectId=3f8521e906e5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3f8521e906e5, replyNumber=0, likeNumber=94, createdTime=2022-03-08, rootId=0, userName=751943081_32627957, userId=b94625296381, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3f8521e906e5, moduleTitle=Clin Lung Cancer: Atezolizumab联合ipilimumab治疗经治的驱动基因阴性的晚期非小细胞肺癌（NSCLC）的安全性和疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3f8521e906e5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1661494, encodeId=a2ea16614940d, content=<a href='/topic/show?id=34a110150800' target=_blank style='color:#2F92EE;'>#驱动基因#</a>, objectTitle=Front Oncol：贝伐单抗或帕博利珠单抗联合培美曲塞+铂类化疗一线治疗驱动基因阴性晚期非鳞非小细胞肺癌(NSCLC)的直接疗效对比, objectType=article, longId=217997, objectId=faae21e997e8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=faae21e997e8, replyNumber=0, likeNumber=140, createdTime=2022-04-08, rootId=0, userName=751943081_32627957, userId=b94625296381, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=faae21e997e8, moduleTitle=Front Oncol：贝伐单抗或帕博利珠单抗联合培美曲塞+铂类化疗一线治疗驱动基因阴性晚期非鳞非小细胞肺癌(NSCLC)的直接疗效对比, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=faae21e997e8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1661492, encodeId=c300166149261, content=<a href='/topic/show?id=34a110150800' target=_blank style='color:#2F92EE;'>#驱动基因#</a>, objectTitle=Nat Rev Cancer：迄今全面癌症驱动基因全景图，66种癌症中的568个致癌基因汇总, objectType=article, longId=200267, objectId=6b7120026ef1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6b7120026ef1, replyNumber=0, likeNumber=91, createdTime=2021-07-18, rootId=0, userName=751943081_32627957, userId=b94625296381, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6b7120026ef1, moduleTitle=Nat Rev Cancer：迄今全面癌症驱动基因全景图，66种癌症中的568个致癌基因汇总, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6b7120026ef1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1661489, encodeId=75771661489ab, content=<a href='/topic/show?id=34a110150800' target=_blank style='color:#2F92EE;'>#驱动基因#</a>, objectTitle=2019年盘点：非小细胞肺癌少见/罕见驱动基因变异治疗进展, objectType=article, longId=186160, objectId=e9f718616028, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e9f718616028, replyNumber=0, likeNumber=114, createdTime=2020-08-03, rootId=0, userName=751943081_32627957, userId=b94625296381, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e9f718616028, moduleTitle=2019年盘点：非小细胞肺癌少见/罕见驱动基因变异治疗进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e9f718616028)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1661487, encodeId=068e166148e53, content=<a href='/topic/show?id=34a110150800' target=_blank style='color:#2F92EE;'>#驱动基因#</a>, objectTitle=热议NGS检测在肺癌中的作用和驱动基因阳性NSCLC的治疗, objectType=article, longId=168968, objectId=dcd216896889, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dcd216896889, replyNumber=0, likeNumber=144, createdTime=2019-07-29, rootId=0, userName=751943081_32627957, userId=b94625296381, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dcd216896889, moduleTitle=热议NGS检测在肺癌中的作用和驱动基因阳性NSCLC的治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dcd216896889)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1661491, encodeId=fa691661491d7, content=<a href='/topic/show?id=34a110150800' target=_blank style='color:#2F92EE;'>#驱动基因#</a>, objectTitle=EBioMedicine：胰腺癌应该存在可有的驱动基因突变, objectType=article, longId=190103, objectId=e0c5190103bf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e0c5190103bf, replyNumber=0, likeNumber=97, createdTime=2020-10-26, rootId=0, userName=751943081_32627957, userId=b94625296381, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e0c5190103bf, moduleTitle=EBioMedicine：胰腺癌应该存在可有的驱动基因突变, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e0c5190103bf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1661490, encodeId=f5081661490c7, content=<a href='/topic/show?id=34a110150800' target=_blank style='color:#2F92EE;'>#驱动基因#</a>, objectTitle=ASCO指南更新：无驱动基因突变IV期非小细胞肺癌一线治疗！, objectType=article, longId=187760, objectId=800018e7605f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=800018e7605f, replyNumber=0, likeNumber=116, createdTime=2020-07-22, rootId=0, userName=751943081_32627957, userId=b94625296381, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=800018e7605f, moduleTitle=ASCO指南更新：无驱动基因突变IV期非小细胞肺癌一线治疗！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=800018e7605f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1661485, encodeId=9ef11661485c9, content=<a href='/topic/show?id=34a110150800' target=_blank style='color:#2F92EE;'>#驱动基因#</a>, objectTitle=Clin Cancer Res：驱动基因阴性肺腺癌研究成果, objectType=article, longId=155385, objectId=47f915538512, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=47f915538512, replyNumber=0, likeNumber=102, createdTime=2019-09-20, rootId=0, userName=751943081_32627957, userId=b94625296381, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=47f915538512, moduleTitle=Clin Cancer Res：驱动基因阴性肺腺癌研究成果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=47f915538512)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1661488, encodeId=5ad51661488f8, content=<a href='/topic/show?id=34a110150800' target=_blank style='color:#2F92EE;'>#驱动基因#</a>, objectTitle=IJC：LAM患者cfDNA中驱动基因和体细胞突变的研究：可能为诊治提供有效的分子标志物及治疗靶点？, objectType=article, longId=174550, objectId=cad11e45500f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cad11e45500f, replyNumber=0, likeNumber=108, createdTime=2019-11-16, rootId=0, userName=751943081_32627957, userId=b94625296381, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cad11e45500f, moduleTitle=IJC：LAM患者cfDNA中驱动基因和体细胞突变的研究：可能为诊治提供有效的分子标志物及治疗靶点？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cad11e45500f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1661486, encodeId=bca61661486ad, content=<a href='/topic/show?id=34a110150800' target=_blank style='color:#2F92EE;'>#驱动基因#</a>, objectTitle=驱动基因阳性非小细胞肺癌脑转移诊治上海专家共识（2019年版）, objectType=article, longId=159821, objectId=c4251598216a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c4251598216a, replyNumber=0, likeNumber=123, createdTime=2019-05-23, rootId=0, userName=751943081_32627957, userId=b94625296381, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c4251598216a, moduleTitle=驱动基因阳性非小细胞肺癌脑转移诊治上海专家共识（2019年版）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c4251598216a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1661484, encodeId=955b16614840f, content=<a href='/topic/show?id=34a110150800' target=_blank style='color:#2F92EE;'>#驱动基因#</a>, objectTitle=驱动基因阴性晚期非小细胞肺癌治疗如何破解？, objectType=article, longId=150185, objectId=62751501850f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=62751501850f, replyNumber=0, likeNumber=86, createdTime=2019-03-14, rootId=0, userName=751943081_32627957, userId=b94625296381, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=62751501850f, moduleTitle=驱动基因阴性晚期非小细胞肺癌治疗如何破解？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=62751501850f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1661483, encodeId=a61116614834c, content=<a href='/topic/show?id=34a110150800' target=_blank style='color:#2F92EE;'>#驱动基因#</a>, objectTitle=ASCO 2018：阿帕替尼联合化疗能显著改善驱动基因阴性NSCLC的结局, objectType=article, longId=139742, objectId=9d4d139e4292, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9d4d139e4292, replyNumber=0, likeNumber=96, createdTime=2019-04-13, rootId=0, userName=751943081_32627957, userId=b94625296381, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9d4d139e4292, moduleTitle=ASCO 2018：阿帕替尼联合化疗能显著改善驱动基因阴性NSCLC的结局, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9d4d139e4292)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1661482, encodeId=246b1661482bf, content=<a href='/topic/show?id=34a110150800' target=_blank style='color:#2F92EE;'>#驱动基因#</a>, objectTitle=J Thorac Oncol：放疗外科治疗驱动基因阳性多发NSCLC脑转移, objectType=article, longId=129876, objectId=38a11298e67e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=38a11298e67e, replyNumber=0, likeNumber=122, createdTime=2018-04-17, rootId=0, userName=751943081_32627957, userId=b94625296381, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=38a11298e67e, moduleTitle=J Thorac Oncol：放疗外科治疗驱动基因阳性多发NSCLC脑转移, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=38a11298e67e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1661480, encodeId=1c4316614808d, content=<a href='/topic/show?id=34a110150800' target=_blank style='color:#2F92EE;'>#驱动基因#</a>, objectTitle=Nat Genet：研究发现浸润性小叶癌新型驱动基因, objectType=article, longId=104261, objectId=1b13104261c9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1b13104261c9, replyNumber=0, likeNumber=106, createdTime=2017-09-10, rootId=0, userName=751943081_32627957, userId=b94625296381, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1b13104261c9, moduleTitle=Nat Genet：研究发现浸润性小叶癌新型驱动基因, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1b13104261c9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1661481, encodeId=3f8c1661481ca, content=<a href='/topic/show?id=34a110150800' target=_blank style='color:#2F92EE;'>#驱动基因#</a>, objectTitle=Gut：食管鳞状细胞癌和腺癌突变模式和驱动基因研究, objectType=article, longId=112047, objectId=322a11204e42, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=322a11204e42, replyNumber=0, likeNumber=118, createdTime=2018-08-04, rootId=0, userName=751943081_32627957, userId=b94625296381, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=322a11204e42, moduleTitle=Gut：食管鳞状细胞癌和腺癌突变模式和驱动基因研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=322a11204e42)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

驱动基因

2020-05-29

梅斯管理员

#狼疮性肾炎# #生物信息学# #驱动基因#

Front Immunol:基于综合生物信息学和机器学习的狼疮性肾炎驱动基因鉴定

2024-01-07发表于上海

751943081_32627957

#驱动基因#

肺癌丨真实世界数据，哪些驱动基因突变可获益于免疫治疗

2023-06-04

751943081_32627957

#驱动基因#

Transl Lung Cancer Res: 无驱动基因突变的转移性NSCLC患者二线多西他赛+ramucirumab（雷莫芦单抗）治疗的疗效

2022-08-29

751943081_32627957

#驱动基因#

J Thorac Oncol：Durvalumab +tremelimumab联合或不联合化疗一线治疗驱动基因阴性的转移性NSCLC患者的疗效和安全性

2022-09-29

751943081_32627957

#驱动基因#

贝伐珠单抗在肺癌驱动基因阴性的治疗

2022-01-11

751943081_32627957

#驱动基因#

Clin Lung Cancer: Atezolizumab联合ipilimumab治疗经治的驱动基因阴性的晚期非小细胞肺癌（NSCLC）的安全性和疗效

2022-03-08

751943081_32627957

#驱动基因#

Front Oncol：贝伐单抗或帕博利珠单抗联合培美曲塞+铂类化疗一线治疗驱动基因阴性晚期非鳞非小细胞肺癌(NSCLC)的直接疗效对比

2022-04-08

751943081_32627957

#驱动基因#

Nat Rev Cancer：迄今全面癌症驱动基因全景图，66种癌症中的568个致癌基因汇总

2021-07-18

751943081_32627957

#驱动基因#

2019年盘点：非小细胞肺癌少见/罕见驱动基因变异治疗进展

2020-08-03

751943081_32627957

#驱动基因#

热议NGS检测在肺癌中的作用和驱动基因阳性NSCLC的治疗

2019-07-29

751943081_32627957

#驱动基因#

EBioMedicine：胰腺癌应该存在可有的驱动基因突变

2020-10-26

751943081_32627957

#驱动基因#

ASCO指南更新：无驱动基因突变IV期非小细胞肺癌一线治疗！

2020-07-22

751943081_32627957

#驱动基因#

Clin Cancer Res：驱动基因阴性肺腺癌研究成果

2019-09-20

751943081_32627957

#驱动基因#

IJC：LAM患者cfDNA中驱动基因和体细胞突变的研究：可能为诊治提供有效的分子标志物及治疗靶点？

2019-11-16

751943081_32627957

#驱动基因#

驱动基因阳性非小细胞肺癌脑转移诊治上海专家共识（2019年版）

2019-05-23

751943081_32627957

#驱动基因#

驱动基因阴性晚期非小细胞肺癌治疗如何破解？

2019-03-14

751943081_32627957

#驱动基因#

ASCO 2018：阿帕替尼联合化疗能显著改善驱动基因阴性NSCLC的结局

2019-04-13

751943081_32627957

#驱动基因#

J Thorac Oncol：放疗外科治疗驱动基因阳性多发NSCLC脑转移

2018-04-17

751943081_32627957

#驱动基因#

Nat Genet：研究发现浸润性小叶癌新型驱动基因

2017-09-10

751943081_32627957

#驱动基因#

Gut：食管鳞状细胞癌和腺癌突变模式和驱动基因研究

2018-08-04